CTBP1 and clear cell renal carcinoma: LINC01426 contributes to clear cell renal cell carcinoma progression by modulating CTBP1/miR-423-5p/FOXM1 axis via interacting with IGF2BP1 [39], and to lung cancer progression via AZGP1 and predicts poor prognosis in patients with LUAD [40].